Gyre Therapeutics, Inc. GYRE Net Interest Income
Discontinued — last reported Q4 '25
Net Interest Income at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Gyre Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InterestIncomeExpenseNet.
The official record: Gyre Therapeutics, Inc.’s 10-K, filed March 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Gyre Therapeutics, Inc.'s net interest income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Gyre Therapeutics, Inc.'s net interest income?
- Gyre Therapeutics, Inc. (GYRE) reported net interest income of $436.75K in Q4 2025.
- How has Gyre Therapeutics, Inc.'s net interest income changed year-over-year?
- Gyre Therapeutics, Inc.'s net interest income increased by 26.2% year-over-year, from $346K to $436.75K.
- What is the long-term trend for Gyre Therapeutics, Inc.'s net interest income?
- Over 3 years (2022 to 2025), Gyre Therapeutics, Inc.'s net interest income has grown at a 34.0% compound annual growth rate (CAGR), from $726K to $1.75M.
- What does net interest income mean?
- This metric is calculated as the difference between interest income earned on cash and investments and interest expense paid on debt obligations. It reflects the net impact of the company's treasury management and financing activities on the bottom line. A positive value indicates that the company generates more from its liquid assets than it pays to service its liabilities.